Jeremy Goad YOU? Author Swipe

Last 10y

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study Open

Stephen Langley, Jeremy Goad, Stephanie Bell, Lee Foster, Catherine Hodges , et al. · 2024

Objectives The objective of this study is to report the pilot phase of the Targeted Prostate Health Check programme that aims to identify men in the Surrey and Sussex region who have prostate cancer and who failed to be detected during the…

Issue Information Open

Rafael Sánchez, Ruchika Talwar, Olutiwa Akinsola, David F. Penson, Deshin Reddy , et al. · 2024

There is more to disposable endoscopes than whether they

Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer Open

Muhammad Ali, Kendrick Koo, David Chang, Phil Chan, Sheng F. Oon , et al. · 2024

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery Open

David C. Chen, Devan S. Sandhu, J O’Brien, Renu Eapen, Daniel Moon , et al. · 2024

Initially developed during World War II for colour imaging, indocyanine green (ICG) is an injectable, highly water soluble dye with fluorescent properties when examined under near-infrared light [1]. With low rates of complication, ICG was…

Supplementary Materials, Methods and Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Supplementary Materials, Methods and Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Supplementary Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Supplementary Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Data from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Prostate cancer disseminates initially and primarily to regional lymph nodes. However, the nature of interactions between tumor cells and lymphatic endothelial cells (LEC) is poorly understood. In the current study, we have isolated prosta…

Supplementary Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Supplementary Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Data from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Prostate cancer disseminates initially and primarily to regional lymph nodes. However, the nature of interactions between tumor cells and lymphatic endothelial cells (LEC) is poorly understood. In the current study, we have isolated prosta…

Supplementary Materials, Methods and Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis Open

Yiping Zeng, Kenneth Opeskin, Jeremy Goad, Elizabeth D. Williams · 2023

Supplementary Materials, Methods and Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma Open

Cristian Udovicich, Jason Callahan, Mathias Bressel, Wee Loon Ong, Marlon Perera , et al. · 2022

We report on a group of patients undergoing a new type of imaging for suspected advanced kidney cancer, called PSMA PET/CT. This imaging changed the management plan in 49% of the patients. PSMA PET/CT detected metastases in 84% of our pati…

Large and rapid local recurrence of clear cell renal cell carcinoma Open

Alice Thomson, Derek Hennessey, Jeremy Goad, Ned Kinnear · 2021

After radical nephrectomy, clear cell renal cell carcinoma (ccRCC) recurs locally in <3% of patients. Recurrences typically occur 1-2 years postoperatively and grow at 5–20 mm per year. In contrast, this patient’s recurrence was unexpected…

A case of acute-colonic pseudo-obstruction (Ogilvie Syndrome) post robot-assisted radical prostatectomy Open

Mahima Tellambura, Marcus Cumberbatch, Jeremy Goad · 2021

MP64-09 DUCTAL ADENOCARCINOMA OF THE PROSTATE IS ASSOCIATED WITH SHORTER METASTASIS-FREE SURVIVAL Open

Ken Chow, Anthony J. Ryan, Dinesh Agarwal, Damien Bolton, Yee Chan , et al. · 2020

You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II (MP64)1 Apr 2020MP64-09 DUCTAL ADENOCARCINOMA OF THE PROSTATE IS ASSOCIATED WITH SHORTER METASTASIS-FREE SURVIVAL Ken Chow*, Andrew Ryan, Dinesh Agarwal, D…

Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy Open

Jo‐Lynn Tan, Alastair Lamb, Owen W.J. Prall, Courtenay West, Jeremy Goad , et al. · 2020

OC-0277 Interim safety analysis of RAPPORT trial - SABR with pembrolizumab in oligometastatic RCC Open

Shankar Siva, Mathias Bressel, Shahneen Sandhu, Bach Xuan Tran, Jennifer Mooi , et al. · 2019

Intractable acute ischaemic priapism occurring secondary to newly commenced olanzapine Open

Matthew Farag, Jeremy Goad, Catherine Temelcos · 2019

We present a case of intractable acute ischaemic priapism occurring secondary to newly commenced olanzapine. It demonstrates rapid intervention in a stepwise approach aiming to restore penile flaccidity in order to prevent chronic damage t…

Assessment of a European Bladder Cancer Predictive Model for Non-Muscle Invasive Bladder Cancer in an Australian Cohort Open

Matthew Alberto, Stephanie Demkiw, Jeremy Goad, Mark A. Jenkins, Genevieve Duggan , et al. · 2019

Background and Objectives: To validate the European Organization for Research and Treatment of Cancer (EORTC) model using an Australian cohort and to identify variables within our cohort that may predict non-muscle invasive bladder cancer …

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy Open

Mitchell G. Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A. Selth, Stephen Q. Wong , et al. · 2018

Changing face of robot‐assisted radical prostatectomy in Melbourne over 12 years Open

Niranjan Sathianathen, Alastair Lamb, Nathan Lawrentschuk, Jeremy Goad, Justin S. Peters , et al. · 2017

Background This study aims to characterize the trends in disease presentation for robot‐assisted radical prostatectomy ( RARP ) over a 12‐year period in Melbourne, Australia. Methods All patients undergoing an RARP between 2004 and October…

PD53-10 IMPACT OF ADJUVANT TREATMENT ON LONG-TERM QUALITY OF LIFE OF TESTICULAR CANCER SURVIVORS Open

Trung Q Ngo, Jeremy Goad, Anthony Dowling, Lih‐Ming Wong · 2017

You have accessJournal of UrologySexual Function/Dysfunction: Penis/Testis/Urethra: Benign Disease & Malignant Disease II1 Apr 2017PD53-10 IMPACT OF ADJUVANT TREATMENT ON LONG-TERM QUALITY OF LIFE OF TESTICULAR CANCER SURVIVORS Trung Q Ngo…

BCG immunotherapy for non-muscle invasive bladder cancer: is efficacy related to toxicity? Open

Cristian Udovicich, Priscilla Nankivell, Anthony Barberi, Dean Page, Mark A. Jenkins , et al. · 2017

Objectives: To examine the prevalence of local and systemic adverse effects (AEs) associated with Bacillus Calmette-Guerin (BCG) immunotherapy for non-muscle invasive bladder cancer (NMIBC) and to determine if there was any relationsh…

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma Open

Jack Crozier, Nathan Papa, Marlon Perera, Michael John Stewart, Jeremy Goad , et al. · 2017

The findings of the current study highlight the improved oncological outcomes with increased LNY, irrespective of the dissection template. Further prospective research is needed to aid LND data interpretation.

MP54-20 ACCURACY OF ULTRASONOGRAPHY FOR THE EVALUATION OF UROLITHIASIS IN PATIENTS UNDERGOING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: COMPARISON WITH NON-CONTRAST COMPUTED TOMOGRAPHY Open

Lih‐Ming Wong, Vy Thao Tran, Mark A. Jenkins, Anita Clarke, Jeremy Goad , et al. · 2016

You have accessJournal of UrologyStone Disease: Shock Wave Lithotripsy1 Apr 2016MP54-20 ACCURACY OF ULTRASONOGRAPHY FOR THE EVALUATION OF UROLITHIASIS IN PATIENTS UNDERGOING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: COMPARISON WITH NON-CONTRAS…

V4-07 EARLY EXPERIENCE OF ROBOTIC SALVAGE PELVIC LYMPH NODE DISSECTION IN THE GA-68 PSMA PET SCANNING ERA Open

Declan Murphy, Homayoun Zargar, Roderick van den Bergh, Siska Van Bruwaene, Michael S. Hofman , et al. · 2016

You have accessJournal of UrologyRobotics – Prostate/Novel Imaging1 Apr 2016V4-07 EARLY EXPERIENCE OF ROBOTIC SALVAGE PELVIC LYMPH NODE DISSECTION IN THE GA-68 PSMA PET SCANNING ERA Declan Murphy, Homayoun Zargar, Roderick Van Den Bergh, S…

Fetching topic information...